Snippet Search

Searching 11,975,612 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 101 to 125 of 9736 matching articles

Results per page:

... incubation of cells for 20 h with 40 ng/ml  mitomycin 
Bacteriocin Release Protein-Mediated Secretory Expression of Recombinant Chalcone Synthase in Escherichia coli
Bacteriocin Release Protein-Mediated Secretory Expression of Recombinant Chalcone Synthase in Escherichia coli
Zakaria, Iffah Izzati; Rahman, Raja Noor Zaliha Raja Abdul; Salleh, Abu Bakar; Basri, Mahiran
C at OD600 induction time of 0.5 was found ...
... recurrence; bacillus Calmette-Guérin (BCG);  mitomycin 
Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes
Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes
Audenet, François; Traxer, Olivier; Bensalah, Karim; Rouprêt, Morgan
C. ...
... be demonstrated in the commensal strains as  mitomycin 
Barriers to coliphage infection of commensal intestinal flora of laboratory mice
Barriers to coliphage infection of commensal intestinal flora of laboratory mice
Kasman, Laura M
C failed to induce detectable phage. ...
... based on CO2 laser section of the web,  mitomycin 
Endoscopic treatment of anterior glottic webs according to Lichtenberger technique and results on 18 patients
Endoscopic treatment of anterior glottic webs according to Lichtenberger technique and results on 18 patients
Benmansour, N.; Remacle, M.; Matar, N.; Lawson, G.; Bachy, V.; Vorst, S.
application and placement of a temporary ...
... phacoemulsification and trabeculectomy with  mitomycin 
Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial
Collagen matrix vs mitomycin-C in trabeculectomy and combined phacoemulsification and trabeculectomy: a randomized controlled trial
Tanna, Angelo P.; Rademaker, Alfred W.; de Moraes, C. Gustavo; Godfrey, David G.; Sarkisian, Steven R., Jr.; Vold, Steven D.; Ritch, Robert
-C (MMC) vs. ...
... maintained in E medium in the presence of  mitomycin 
Human Papillomavirus Type 31 Life Cycle Methods for Study Using Tissue Culture Models
Human Papillomavirus Type 31 Life Cycle Methods for Study Using Tissue Culture Models
Fehrmann, Frauke; Laimins, Laimonis A.
C-treated J2 3T3 fibroblast feeders. ...
... been well described in GCT patients [22].  Mitomycin 
Contribution of Chemotherapy to the Toxicity of Pelvic Irradiation
Contribution of Chemotherapy to the Toxicity of Pelvic Irradiation
Sehdev, Amikar; W. Marsh, R.
C ...
... cisplatin/oxaliplatin 60-130 mg/m2, and  mitomycin 
Isolated Chemotherapeutic Perfusion of Pelvis as Neoadjuvant or Palliative Therapy for Advanced Cancer of the Rectum
Isolated Chemotherapeutic Perfusion of Pelvis as Neoadjuvant or Palliative Therapy for Advanced Cancer of the Rectum
Wanebo, Harold J.; DiSiena, Michael; Begossi, Giovanni; Belliveau, James; Gustafson, Eric
C 10 to 15 mg/m2 (the latter three ...
... the use of balloon dilatation and topical  mitomycin 
Treatment of multiple-level tracheobronchial stenosis secondary to endobronchial tuberculosis using bronchoscopic balloon dilatation with topical mitomycin-C
Treatment of multiple-level tracheobronchial stenosis secondary to endobronchial tuberculosis using bronchoscopic balloon dilatation with topical mitomycin-C
Faisal, Mohamed; Harun, Hafaruzi; Hassan, Tidi M.; Ban, Andrea Y. L.; Chotirmall, Sanjay H.; Abdul Rahaman, Jamalul Azizi
-C to successful restore airway patency. ...
... or generate them as described in Generating  Mitomycin 
hESC Engineering by Integrase-Mediated Chromosomal Targeting
hESC Engineering by Integrase-Mediated Chromosomal Targeting
Liu, Ying; Lakshmipathy, Uma; Ozgenc, Ali; Thyagarajan, Bhaskar; Lieu, Pauline; Fontes, Andrew; Xue, Haipeng; Scheyhing, Kelly; MacArthur, Chad; Chesnut, Jonathan D.
C-Treated MEFs. 2. Dulbecco's Modified ...
... second most frequently used substance was  mitomycin 
The Historical Perspective of Gastric Cancer
The Historical Perspective of Gastric Cancer
Rogy, Michael A.; Bünger, Marius A.
C, isolated from populations of ...
... over radiotherapy alone and that of  mitomycin 
Anal Cancer
Anal Cancer
Branagan, Graham; Moran, Brendan
. ...
... (see Note 1). 2. Solution of 200 μg/mL  mitomycin 
Classical Human Epidermal Keratinocyte Cell Culture
Classical Human Epidermal Keratinocyte Cell Culture
Rasmussen, Cathy; Thomas-Virnig, Christina; Allen-Hoffmann, B. Lynn
-C in HEPES-Buffered Earle’s Salts, ...
... cellulose sponge fragments used to apply  mitomycin 
Foreign body granulomas secondary to retained sponge fragment following mitomycin C trabeculectomy
Foreign body granulomas secondary to retained sponge fragment following mitomycin C trabeculectomy
Al-Shahwan, Sami; Edward, Deepak P.
C on the scleral surface. ...
... following treatment of strain MGAS6180 with  mitomycin 
Lateral gene transfer of streptococcal ICE element RD2 (region of difference 2) encoding secreted proteins
Lateral gene transfer of streptococcal ICE element RD2 (region of difference 2) encoding secreted proteins
Sitkiewicz, Izabela; Green, Nicole M; Guo, Nina; Mereghetti, Laurent; Musser, James M
C, a DNA damaging agent. ...
... Invitrogen) Gelatin (G1890, Sigma)  Mitomycin 
Generation of Induced Pluripotent Stem Cells from Mesenchymal Stromal Cells Derived from Human Third Molars (Method)
Generation of Induced Pluripotent Stem Cells from Mesenchymal Stromal Cells Derived from Human Third Molars (Method)
Oda, Yasuaki; Ohnishi, Hiroe; Yuba, Shunsuke; Ohgushi, Hajime
C (134-07911, Wako, Japan) FuGENE® HD ...
... Haemolytic uraemic syndrome occurs with  mitomycin 
Anticancer Drug—Induced Kidney Disorders
Anticancer Drug—Induced Kidney Disorders
Kintzel, Polly E.
administration. ...
... reduction including agents such as  mitomycin 
Bioreductive Prodrugs for Cancer Therapy
Bioreductive Prodrugs for Cancer Therapy
Seddon, Beatrice; Kelland, Lloyd R.; Workman, Paul
C and EO9. ...
... at room temperature for several weeks. 4.  Mitomycin 
Human Embryonic Stem Cells for Tissue Engineering
Human Embryonic Stem Cells for Tissue Engineering
Kitsberg, Daniel
-C-containing medium: Prepare ...
... lines for LMBC). HAIC protocols included  mitomycin 
Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters
Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters
Tewes, Mitra; Peis, Michael Wilhelm; Bogner, Simon; Theysohn, Jens M.; Reinboldt, Marcus Paul; Schuler, Martin; Welt, Anja
/5-FU (70%), ...
... intraperitoneal chemotherapy with  mitomycin 
Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model
Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model
Raue, Wieland; Kilian, Maik; Braumann, Chris; Atanassow, Vladimir; Makareinis, Anna; Caldenas, Sonja; Schwenk, Wolfgang; Hartmann, Jens
or gemcitabine, photodynamic therapy or ...
... of certain chemotherapeautic agents (  mitomycin 
The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review
The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review
Bhatt, Aditi; Glehen, Olivier
C, cisplatin, oxaliplatin) and increases ...
... into aliquots and store at 20°C. 4.  Mitomycin 
Cripto Signaling in Differentiating Embryonic Stem Cells
Cripto Signaling in Differentiating Embryonic Stem Cells
Minchiotti, Gabriella; Parisi, Silvia; Persico, M. Graziella
C: to a vial containing 2 mg ...
... and safety of primary trabeculectomy with  mitomycin 
Five-year results of trabeculectomy with mitomycin C
Five-year results of trabeculectomy with mitomycin C
Beckers, Henny J. M.; Kinders, Katja C.; Webers, Carroll A. B.
C were retrospectively studied. ...
... setting with doxorubicin monotherapy or  mitomycin 
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
Knappskog, Stian; Chrisanthar, Ranjan; Løkkevik, Erik; Anker, Gun; Østenstad, Bjørn; Lundgren, Steinar; Risberg, Terje; Mjaaland, Ingvil; Leirvaag, Beryl; Miletic, Hrvoje; Lønning, Per E
combined with 5-fluorouracil. ...